BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//CCMG | CCGM - ECPv6.15.20//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://ccmg.51-222-78-205.ygkweb.ca
X-WR-CALDESC:Events for CCMG | CCGM
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/Toronto
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20240310T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20241103T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20250309T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20251102T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20260308T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20261101T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20250228T120000
DTEND;TZID=America/Toronto:20250228T130000
DTSTAMP:20260628T160606
CREATED:20250131T214231Z
LAST-MODIFIED:20250211T163251Z
UID:10000058-1740744000-1740747600@ccmg.51-222-78-205.ygkweb.ca
SUMMARY:Can-GARD/CCMG – The Leading Strand Series
DESCRIPTION:This series is for genetics health professionals led by the Canadian College of Medical Genetics and co-sponsored by Can-GARD. Speakers will be translation-focused researchers\, clinicians and innovators.  The series will help attendees anticipate\, access\, and apply new approaches and technologies for patient care. \nThe Can-GARD/CCMG Leading Strand Series is a self-approved group learning activity (Section 1) as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada. \nTo register\, click the button below or go to https://us06web.zoom.us/webinar/register/WN_MzE5qgCSQCyPI-X9Ys7_IQ  \n \n  \n  \n  \n  \nFriday February 28\, 2025\n12:00pm – 1:00pm ET \nGenome Mapping – From Development to Clinical Implementation \nOptical Genome Mapping is a non-sequencing based technology that can be used to analyze genomes for structural variation at high resolution. This technology can replace or supplement current cytogenetic techniques such as karyotype\, FISH and chromosomal microarray. The presentation will review how Optical Genome Mapping has been used to better define structural variation in hematologic malignancies in clinical samples as well as applications in pre- and post-natal cytogenetics. \nLearning Objectives: \n\nCompare the strengths and limitations of genome mapping techniques for the detection of genome wide structural variants.\nConsider the changes in clinical practice with the application of new high resolution technologies.\n\nSpeaker: Dr. Adam Smith \nBio: Dr. Smith is a dual-boarded Clinical Cytogeneticist and Clinical Molecular Geneticist certified by the Canadian College of Medical Geneticists (CCMG). Dr. Smith is also a fellow of the American College of Genetics and Genomics (FACMG) and a Certified Laboratory Geneticist (erCLG) by the European Board of Medical Genetics. \nDr. Smith completed his Master’s degree and Ph.D. at the University of Toronto. Dr. Smith is currently a Clinical Laboratory Director at Labcorp. He is also an internationally recognized leader in the implementation of Optical Genome Mapping in a clinical setting. Dr. Smith received the CCMG Genetics and Genomics Award for Innovation (2024) for his work in Optical Genome Mapping.
URL:https://ccmg.51-222-78-205.ygkweb.ca/event/can-gard-ccmg-the-leading-strand-series-3-6/
ORGANIZER;CN="CCMG | CCGM":MAILTO:info@ccmg-ccgm.org
END:VEVENT
END:VCALENDAR